The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / I••• B••••••••• C••••••••• B•••••••

T••••••• S••••• Capital Partners Acquires I••• B••••••••• C••••••••• B•••••••

Platform acquisitionannouncedannounced Jun 3, 2016Fact
What happened
Target
I••• B••••••••• C••••••••• B•••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
MA, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • J•••• A••• C•••••Deal partnerconfirmed
    “Jim C•••••, Managing Partner at TSCP commented, “We’re excited to partner with management to build upon I•••’s leading orthobiologics platform.””
  • T••••••• S••••• C•••••• M•••••• L••Sponsorconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis with $1.5 billion of assets under management, announced today that it has acquired the commercial operations of I••• B•••••••• (I•••) headquartered in Hopkinton, Massachusetts.”
Side not stated
Evidence
“T••••••• S••••• Capital Partners Acquires I••• B••••••••• C••••••••• B•••••••”
Press release wires (PR Newswire, GlobeNewswire, B••••••• Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
T••••••• S••••• Capital Partners Acquires I••• B••••••••• C••••••••• B••••••• | Private Equity Intelligence | DFX